Skip to main content

Table 4 Associations between ultrasound biomarkers and clinical data and serology tests

From: Applicability of multiple quantitative ultrasound liver biomarkers in children and adolescents with severe obesity

Variable

ATI (dB/cm/MHz)

SWE (kPa)

SWD (m/s)/kHz

 

Beta (95% CI)

p

R2

Beta (95% CI)

p

R2

Beta (95% CI)

p

R2

BMI

−0.01 (−0.02;−0.00)

0.0007

0.20

0.12 (−0.01;0.25)

0.066

0.07

0.09 (−0.06;0.25)

0.22

0.03

BMI SDS

−0.05 (−0.09;−0.02)

0.0060

0.14

0.71 (0.05;1.37)

0.035

0.09

0.56 (−0.35;1.48)

0.22

0.03

AST (ukat/L)

0.06 (−0.05;0.17)

0.28

0.03

−1.92 (−4.08;0.23)

0.079

0.08

−1.78 (−3.63;0.08)

0.060

0.09

ALT (ukat/L)

0.01 (−0.03;0.05)

0.56

0.01

−0.56 (−1.39;0.28)

0.19

0.04

−0.34 (−1.09;0.40)

0.36

0.02

HbA1c (mmol/mol)

0.00 (−0.01;0.01)

0.60

0.01

−0.20 (−0.36;−0.04)

0.015

0.13

−0.03 (−0.18;0.12)

0.67

0.00

Cholesterol (mmol/L)

0.03 (−0.01;0.07)

0.17

0.04

−0.24 (−1.20;0.73)

0.62

0.01

0.12 (−0.73;0.98)

0.77

0.00

Triglyceride (mmol/L)

0.07 (0.02;0.13)

0.015

0.12

−0.88 (−2.26;0.50)

0.20

0.04

0.23 (−0.99;1.46)

0.70

0.00

  1. The β value for each independent variable indicates the expected change in the dependent variable for a one-unit increase in that independent variable, assuming all other variables in the model are held constant. P probability value, BMI body mass index, SDS standard deviation score, AST aspartate aminotransferase, ALT alanine aminotransferase. CI confidence interval, ATI attenuation imaging, SWE shear wave elastography, SWD shear wave dispersion